Rockefeller Capital Management L.P. Ascendis Pharma A/S Transaction History

Rockefeller Capital Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	BUY	$99.42 - $131.97 $795 - $1,055	8 Added 50.0%	24 $1,000
Q3 2022 Nov 02, 2022	SELL	$84.03 - $110.23 $9,411 - $12,345	-112 Reduced 87.5%	16 $1,000
Q2 2022 Aug 12, 2022	BUY	$78.08 - $117.61 $9,213 - $13,877	118 Added 1180.0%	128 $11,000
Q1 2022 May 13, 2022	SELL	$102.18 - $135.75 $1,941 - $2,579	-19 Reduced 65.52%	10 $1,000
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $3,685 - $4,920	29 New	29 $3,000
Q3 2021 Nov 12, 2021	SELL	$112.67 - $176.92 $5,633 - $8,846	-50 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$124.92 - $173.33 $6,246 - $8,666	50 New	50 $6,000
Q2 2020 Aug 12, 2020	SELL	$110.87 - $156.01 $11,087 - $15,601	-100 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$62.15 - $129.99 $6,215 - $12,999	100 New	100 $12,000

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.